ES2062406T3 - Nuevos compuestos de morfolinol, su preparacion y uso. - Google Patents
Nuevos compuestos de morfolinol, su preparacion y uso.Info
- Publication number
- ES2062406T3 ES2062406T3 ES90311851T ES90311851T ES2062406T3 ES 2062406 T3 ES2062406 T3 ES 2062406T3 ES 90311851 T ES90311851 T ES 90311851T ES 90311851 T ES90311851 T ES 90311851T ES 2062406 T3 ES2062406 T3 ES 2062406T3
- Authority
- ES
- Spain
- Prior art keywords
- compounds
- morfolinol
- preparation
- new
- carbon atoms
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
- C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
- C07D265/30—1,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings
- C07D265/32—1,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings with oxygen atoms directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurosurgery (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biomedical Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Psychiatry (AREA)
- Pharmacology & Pharmacy (AREA)
- Neurology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Medicinal Preparation (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
NUEVOS (25, 35, 5R) MORFOLINOLES QUE TIENEN LA FORMULA (I) JUNTO CON LAS RAMIFICACIONES (+-) *, 5S ELEVADO *) DEL MISMO Y SUS SALES, EN DONDE X ES UN HIDROGENO, UN ALQUILO DE 1 A 6 ATOMOS DE CARBONO, UN CICLOALQUILO DE 3 A 6 ATOMOS DE CARBONO O UN GRUPO -CH SUB 2DE X ELEVADO 1 ES UN CICLOALQUILO DE 3 A 6 ATOMOS DE CARBONO. EL COMPUESTO TIENE VARIAS APLICACIONES MEDICAS, SOBRE TODO EN EL TRATAMIENTO DE ENFERMEDADES MENTALES DE LAS PERSONAS COMO POR EJEMPLO LA DEPRESION.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB898924528A GB8924528D0 (en) | 1989-10-31 | 1989-10-31 | Heterocyclic pharmaceutical compounds,preparation and use |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2062406T3 true ES2062406T3 (es) | 1994-12-16 |
Family
ID=10665482
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES90311851T Expired - Lifetime ES2062406T3 (es) | 1989-10-31 | 1990-10-30 | Nuevos compuestos de morfolinol, su preparacion y uso. |
Country Status (19)
Country | Link |
---|---|
US (1) | US5104870A (es) |
EP (1) | EP0426416B1 (es) |
JP (1) | JP2873076B2 (es) |
AT (1) | ATE101604T1 (es) |
AU (1) | AU645763B2 (es) |
CA (1) | CA2028893C (es) |
DE (1) | DE69006682T2 (es) |
DK (1) | DK0426416T3 (es) |
ES (1) | ES2062406T3 (es) |
FI (1) | FI94753C (es) |
GB (1) | GB8924528D0 (es) |
HU (2) | HU207304B (es) |
IE (1) | IE66115B1 (es) |
LV (1) | LV11030B (es) |
MX (1) | MX9203219A (es) |
NZ (1) | NZ235882A (es) |
PT (1) | PT95735B (es) |
SG (1) | SG28347G (es) |
ZA (1) | ZA908696B (es) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9108629D0 (en) * | 1991-04-23 | 1991-06-12 | Wellcome Found | Heterocyclic pharmaceutical compounds,preparation and use |
WO1999025355A1 (en) * | 1997-11-14 | 1999-05-27 | Glaxo Group Ltd. | Method of treating addiction to nicotine products |
MA26693A1 (fr) * | 1998-09-28 | 2004-12-20 | Glaxo Group Ltd | Compositions pour administration par voie buccale |
EP1220673A2 (en) * | 1999-10-13 | 2002-07-10 | Glaxo Group Limited | Morpholinol derivatives for the treatment of obesity |
EP2266590A3 (en) | 2002-02-22 | 2011-04-20 | Shire LLC | Active agent delivery sytems and methods for protecting and administering active agents |
EP1968603A4 (en) * | 2006-01-03 | 2013-01-16 | Algebra Inc | THERAPEUTIC AMINARYLSULFONAMIDE CONJUGATE COMPOUNDS |
EP2419400A1 (en) | 2009-04-15 | 2012-02-22 | Research Triangle Institute | Monoamine reuptake inhibitors |
JP5952267B2 (ja) * | 2010-05-21 | 2016-07-13 | リサーチ・トライアングル・インスティチュート | 薬物依存を処置するためのヒドロキシブプロピオン類似体(政府支援研究または開発) |
CA2800220C (en) | 2010-05-21 | 2019-04-30 | Research Triangle Institute | Phenylmorpholines and analogues thereof |
CN105949142B (zh) * | 2016-05-21 | 2018-03-27 | 南华大学 | 具有抗抑郁活性的单一手性化合物及其制备方法和应用 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3117967A (en) * | 1962-04-02 | 1964-01-14 | Smith Kline French Lab | 2-biphenylyl-2-hydroxy-morpholinium halides |
FR2553413B1 (fr) * | 1983-10-17 | 1986-03-21 | Lafon Labor | Derives de 4-alkyl-2-hydroxy-3-methyl-2-phenyl-morpholine, procede de preparation et utilisation en therapeutique |
GB8417170D0 (en) * | 1984-07-05 | 1984-08-08 | Wellcome Found | Heterocyclic pharmaceutical compounds |
-
1989
- 1989-10-31 GB GB898924528A patent/GB8924528D0/en active Pending
-
1990
- 1990-10-30 AU AU65639/90A patent/AU645763B2/en not_active Ceased
- 1990-10-30 HU HU906935A patent/HU207304B/hu not_active IP Right Cessation
- 1990-10-30 SG SG1995904223A patent/SG28347G/en unknown
- 1990-10-30 CA CA002028893A patent/CA2028893C/en not_active Expired - Fee Related
- 1990-10-30 ES ES90311851T patent/ES2062406T3/es not_active Expired - Lifetime
- 1990-10-30 FI FI905356A patent/FI94753C/fi not_active IP Right Cessation
- 1990-10-30 JP JP2293476A patent/JP2873076B2/ja not_active Expired - Fee Related
- 1990-10-30 EP EP90311851A patent/EP0426416B1/en not_active Expired - Lifetime
- 1990-10-30 NZ NZ235882A patent/NZ235882A/xx unknown
- 1990-10-30 PT PT95735A patent/PT95735B/pt not_active IP Right Cessation
- 1990-10-30 IE IE388890A patent/IE66115B1/en not_active IP Right Cessation
- 1990-10-30 AT AT90311851T patent/ATE101604T1/de not_active IP Right Cessation
- 1990-10-30 DE DE69006682T patent/DE69006682T2/de not_active Expired - Fee Related
- 1990-10-30 ZA ZA908696A patent/ZA908696B/xx unknown
- 1990-10-30 DK DK90311851.1T patent/DK0426416T3/da active
-
1991
- 1991-04-02 US US07/680,637 patent/US5104870A/en not_active Expired - Lifetime
-
1992
- 1992-06-24 MX MX9203219A patent/MX9203219A/es unknown
-
1995
- 1995-02-09 LV LVP-95-27A patent/LV11030B/en unknown
- 1995-05-09 HU HU95P/P00125P patent/HU211304A9/hu unknown
Also Published As
Publication number | Publication date |
---|---|
SG28347G (en) | 1995-09-18 |
AU6563990A (en) | 1991-05-09 |
EP0426416A1 (en) | 1991-05-08 |
IE903888A1 (en) | 1991-05-08 |
CA2028893C (en) | 2000-10-10 |
EP0426416B1 (en) | 1994-02-16 |
HU211304A9 (en) | 1995-11-28 |
CA2028893A1 (en) | 1991-05-01 |
NZ235882A (en) | 1993-05-26 |
DK0426416T3 (da) | 1994-03-14 |
FI94753B (fi) | 1995-07-14 |
US5104870A (en) | 1992-04-14 |
HUT57748A (en) | 1991-12-30 |
AU645763B2 (en) | 1994-01-27 |
PT95735A (pt) | 1991-09-13 |
ZA908696B (en) | 1992-07-29 |
HU207304B (en) | 1993-03-29 |
ATE101604T1 (de) | 1994-03-15 |
FI94753C (fi) | 1995-10-25 |
DE69006682T2 (de) | 1994-08-04 |
GB8924528D0 (en) | 1989-12-20 |
IE66115B1 (en) | 1995-12-13 |
JP2873076B2 (ja) | 1999-03-24 |
LV11030B (en) | 1996-08-20 |
JPH03206084A (ja) | 1991-09-09 |
MX9203219A (es) | 1992-07-01 |
DE69006682D1 (de) | 1994-03-24 |
HU906935D0 (en) | 1991-05-28 |
PT95735B (pt) | 1998-01-30 |
FI905356A0 (fi) | 1990-10-30 |
LV11030A (lv) | 1996-02-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2071681T3 (es) | Compuestos macrociclicos. | |
ATE85608T1 (de) | Verbindungen mit biologischer aktivitaet. | |
NO931917D0 (no) | Farmasoeytiske forbindelser | |
HK1007143A1 (en) | Benzoxazine compounds and pharmaceutical use thereof | |
ES2062406T3 (es) | Nuevos compuestos de morfolinol, su preparacion y uso. | |
ATE53941T1 (de) | Verwendung von sophoroselipid-lacton zur bekaempfung von kopfschuppen und koerpergeruch. | |
DE68917772D1 (de) | 2-Alkyl-3-benzoylbenzofurane und diese enthaltende pharmazeutische Zusammensetzungen. | |
ATE114154T1 (de) | Thienotriazolodiazepine und ihre pharmazeutische verwendung. | |
ATE71092T1 (de) | Hydroxybutenolid-derivate, ihre herstellung und ihre verwendung. | |
DE3768516D1 (de) | Chinonamide, deren herstellung und anwendung. | |
EP0270046A3 (en) | Pharmaceutical composition for treatment of cataract | |
DK7286A (da) | Octahydroindoliziner | |
DE3780191D1 (de) | Octahydroindolizine analgesica und 7-keto-zwischenprodukte. | |
ATE43594T1 (de) | 3-alkoxy-2-(n-pyrrolidino)-n-pyridyl-n-furyl(od r thienyl)-methyl-propylamine, ihre herstellung und diese enthaltende pharmazeutische mittel. | |
KR910021244A (ko) | 당뇨병성 괴저 치료제 | |
ATE55123T1 (de) | Alkylcarbonsaeureamide von pyridinalkylaminen, ihre herstellung und ihre verwendung als arzneimittel. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG2A | Definitive protection |
Ref document number: 426416 Country of ref document: ES |